Biocept Inc. (BIOCQ) — Working Capital to Net Assets Ratio
Biocept Inc. (BIOCQ) has a Working Capital to Net Assets ratio of 1364.8% as of June 2023. Working capital of $3.96 Million (current assets of $8.86 Million minus current liabilities of $4.90 Million) is measured against net assets of $290.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see BIOCQ asset base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Biocept Inc. Working Capital to Net Assets (2019–2022)
This chart shows how Biocept Inc.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the ratio stands at 1364.8%, reflecting working capital of $3.96 Million against net assets of $290.00K USD. Explore Biocept Inc. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Biocept Inc. (2019–2022)
The table below presents the year-by-year Working Capital to Net Assets ratio for Biocept Inc. from 2019 to 2022, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read BIOCQ current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 122.3% | $10.84 Million | $8.86 Million | $16.34 Million | $5.51 Million | ▲ +31.8 pp |
| 2021 | 90.5% | $33.92 Million | $37.48 Million | $45.69 Million | $11.77 Million | ▲ +5.7 pp |
| 2020 | 84.8% | $20.10 Million | $23.69 Million | $32.59 Million | $12.49 Million | ▲ +10.4 pp |
| 2019 | 74.4% | $8.33 Million | $11.20 Million | $13.89 Million | $5.56 Million | — |